Business Context and Reporting Period
Company: The Procter & Gamble Company (P&G)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended September 30, 2024 (Fiscal Q1 2025)
Business Overview: P&G is a global leader in fast-moving consumer goods, operating across five reportable segments: Beauty, Grooming, Health Care, Fabric & Home Care, and Baby, Feminine & Family Care. The company sells products in approximately 180 countries.
Key Financial Metrics
| Metric ($ millions, except per share) | Q1 2024 | Q1 2023 |
|---|---|---|
| Net Sales | $21,737 | $21,871 |
| Operating Income | $5,797 | $5,767 |
| Net Earnings | $3,987 | $4,556 |
| Net Earnings Attributable to P&G | $3,959 | $4,521 |
| Diluted EPS | $1.61 | $1.83 |
| Operating Cash Flow | $4,302 | $4,904 |
| Adjusted Free Cash Flow | $3,871 | N/A |
| Cash and Cash Equivalents (End of Period) | $12,156 | $9,733 |
| Total Debt (Current + Long-Term) | $36,153 | N/A |
Note: Total Debt calculated as Debt due within one year ($10,409) + Long-term debt ($25,744).
Material Changes vs. Prior Period
- Revenue: Net sales decreased 1% to $21.7 billion. Organic sales increased 2%, driven by pricing (+1%) and volume/mix, but were offset by unfavorable foreign exchange (-1%).
- Profitability: Net earnings declined 12% to $4.0 billion. This decrease was primarily driven by a $0.8 billion after-tax incremental restructuring charge related to the liquidation of operations in Argentina and Nigeria.
- EPS: Diluted EPS fell 12% to $1.61. However, Core EPS (excluding restructuring charges) increased 5% to $1.93.
- Segment Performance:
- Beauty: Sales down 5% (driven by SK-II decline and volume decrease).
- Health Care: Sales up 2% (driven by mix and pricing).
- Fabric & Home Care: Sales up 1% (driven by volume and mix).
- Grooming: Sales flat (volume growth offset by mix and FX).
- Baby, Feminine & Family Care: Sales down 2% (volume and FX headwinds).
- Cash Flow: Operating cash flow decreased $602 million year-over-year, largely due to working capital changes and incentive compensation payments.
Guidance, Outlook, and Risks
- Restructuring: The company completed a limited market portfolio restructuring in Q1 2024, incurring approximately $1.2 billion in total after-tax charges since the program began in late 2023. Future restructuring costs are expected to remain within the historical range of $250–$500 million annually.
- Capital Allocation: P&G reaffirmed its expectation to repurchase $6–$7 billion of shares in fiscal year 2025. In Q1 2024, the company repurchased approximately $1.9 billion of treasury stock.
- Key Risks:
- Foreign Exchange: Significant exposure to currency fluctuations, particularly devaluation in Enterprise Markets (e.g., Argentina, Nigeria), impacting translation and transaction results.
- Intangible Assets: The Gillette indefinite-lived intangible asset remains susceptible to impairment risk due to macroeconomic factors, currency devaluation, and market contraction.
- Commodities: Exposure to oil-derived materials (resins) and paper-based materials (pulp) affecting cost structures.
- Geopolitical: Ongoing war in Russia/Ukraine and global economic volatility.
Investor Verification Checklist
- Restructuring Impact: Verify the sustainability of earnings excluding the one-time $0.8 billion Argentina/Nigeria charge.
- Beauty Segment: Monitor the trajectory of the SK-II brand decline and its impact on the overall Beauty segment margin.
- Foreign Exchange Sensitivity: Assess the potential for further currency devaluation in Enterprise Markets and its effect on future net sales and earnings.
- Share Repurchases: Confirm the execution of the $6–$7 billion buyback program for fiscal 2025 against cash flow generation.
- Intangible Asset Valuation: Review the assumptions (discount rates, growth rates) used for the Gillette brand impairment testing in the next annual review.